miRNA Sequencing and Assay Market Growth Overview

The global miRNA sequencing and assay market is valued at USD 391.73 million in 2024, with projections to reach USD 1.37 billion by 2034, growing at a CAGR of 13.33%. The increasing use of miRNAs in disease diagnosis and treatment development drives this growth.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5363

miRNA Sequencing and Assay Market Overview

MicroRNAs (miRNAs) are a type of small, non-coding RNA, typically less than 200 nucleotides in length, and are part of a larger family of tiny RNAs. miRNAs are the most studied among these molecules. Next-generation sequencing (NGS) has significantly advanced research by offering accurate, high-throughput profiling of small RNA and miRNA molecules. This technology enables the discovery and measurement of both known and new miRNAs, helping to understand their roles in gene regulation and disease pathways. NGS also allows researchers to analyze miRNA expression across various tissue types, developmental stages, and disease conditions, providing insights into their functional importance.

Leading Companies in the miRNA Sequencing and Assay Market

• Thermo Fisher Scientific, Inc.: A global leader in scientific research, Thermo Fisher offers a broad range of products and services, including miRNA sequencing solutions, that help advance molecular biology and genetic research.
• Illumina, Inc.: Known for its next-generation sequencing technologies, Illumina provides comprehensive miRNA profiling and sequencing platforms that support researchers in gene expression and disease studies.
• QIAGEN: Specializing in sample preparation and molecular analysis, QIAGEN offers a variety of miRNA sequencing tools and assays, enabling high-quality RNA analysis for research and diagnostic applications.
• PerkinElmer, Inc.: PerkinElmer develops innovative technologies for genomic research, including miRNA sequencing assays, that aid in the discovery of biomarkers and improve the understanding of genetic diseases.
• Abcam plc: A leading provider of reagents and tools for life sciences, Abcam offers miRNA assays and antibodies for gene expression research and miRNA-related studies.
• New England Biolabs: Renowned for its DNA research products, New England Biolabs provides a range of miRNA-related sequencing tools and reagents for molecular and genetic research.
• Takara Bio Inc.: Takara Bio focuses on genetic research and offers advanced miRNA sequencing and assay products that enable precise gene expression analysis in various research settings.
• Lexogen GmbH: Lexogen specializes in RNA sequencing technologies, offering miRNA sequencing kits and solutions that allow for high-throughput analysis of small RNA molecules.
• Norgen Biotek Corp.: Norgen Biotek is known for its RNA extraction and purification products, including miRNA isolation kits and assays used in various research applications.
• Maravai LifeSciences: Maravai LifeSciences provides products for genetic research, including miRNA sequencing assays, helping researchers investigate the role of miRNAs in gene regulation and disease mechanisms.
• HTG Molecular Diagnostics, Inc.: HTG specializes in molecular diagnostics and provides advanced miRNA profiling assays, enabling more precise and personalized research in oncology and other disease areas.
• Meridian Bioscience, Inc.: Meridian Bioscience develops diagnostic products, including miRNA assays, that aid in disease detection and understanding miRNA’s role in disease processes.
• System Biosciences, LLC: System Biosciences provides tools for genetic research, including miRNA detection kits and assays, which are used to study gene expression and regulation.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/mirna-sequencing-and-assay-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5363

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare